NEW YORK, April 9 - Eisai, a Japanese health care and pharmaceutical company, has signed a multi-year subscription to Incyte Genomics' LifeSeq Gold human sequence and ZooSeq animal model databases, the company said Monday.

Researchers at Eisai, which is based in Tokyo, will have 24-hour online access to the databases and to information technology support, Incyte said in a statement.